M.D. Anderson Cancer Center News

Powel Brown, M.D., Ph.D. is professor of medicine and cancer prevention and clinical cancer prevention department chairman at the University of Texas M. D. Anderson Cancer Center and an editorial... PHILADELPHIA - Researchers have found that hormones produced during pregnancy induce a protein that directly inhibits the growth of breast cancer.

The U.S. Preventive Services Task Force's controversial new breast cancer screening recommendations are specifically for women who are at "normal" risk of breast cancer.

Two signaling pathways essential to normal human development - the Wnt/Wingless and epidermal growth factor receptor pathways - interact in ways that can promote tumor cell invasion and metastasis, researchers from The University of Texas M. D. Anderson Cancer Center report in the Nov.

E-mail: berringtona@mail.nih.gov Received 16 September 2009; Revised 16 October 2009; Accepted 19 October 2009; Published online 24 November 2009.

Abstract Background: Despite having a dramatically larger surface area than the large intestine, the small intestine is an infrequent site for the development of adenocarcinoma.

Nov 23, 2009 - ARIAD Pharmaceuticals, Inc. today announced that the Company and collaborating investigators from five major oncology research centers in the United States will present data from a Phase 1 clinical trial of ARIAD's investigational, multi-targeted kinase inhibitor and pan-BCR-ABL inhibitor, AP24534 , at the 51st Annual Meeting of the ...

Although major cancer-awareness groups such as the American Cancer Society and Susan G. Komen for the Cure disagree with the new guidance on mammograms, continuing to recommend routine mammograms for women 40 and up, guidance on self-exams has been trending toward the task force's suggestions.

Guidelines released Monday by the U.S. Preventative Services Task Force saying mammograms before age 50 and breast self-exams are unnecessary is bunk, says breast cancer survivor Suzanne Payne, 61, Appleton.

Main Category: Biology / Biochemistry Also Included In: Medical Students / Training Article Date: 19 Nov 2009 The Howard Hughes Medical Institute has committed four years' worth of funding for an innovative biomedical training program between Rice University and the University of Texas M.D. Anderson Cancer Center.

Nov 17, 2009 - Exelixis, Inc. today reported interim data from an ongoing phase 1 dose-escalation trial of XL147 in combination with paclitaxel and carboplatin in patients with advanced solid tumors.

Nov. 13, 2009 By CINDY GEORGE Hispanics accounted for more than half of the 95 swine flu-related deaths in Texas in the first six months of the H1N1 pandemic, an analysis by the state health department found.

Whether you smoke three cigarettes or three packs of cigarettes a day, kicking the habit is difficult.

One day in medical clinics, the big picture of a patient's state of health may be found in little pictures from the mouth, says Li Mao, MD, a new professor at the University of Maryland Dental School.

Non-spherical nano-/micro-particles can drift laterally in a linear laminar flow under the concurrent effect of hydrodynamic and inertial forces.

There are several reasons that survivors experience pain: nerve damage or injury from surgery or radiation.

From left, David Lee, president of Nano3D Biosciences; Glauco Souza, chief technology officer and a co-inventor; and Dr.

The University of Texas M. D. Anderson Cancer Center's top nursing executive has been recognized with nursing's highest honor.

Registration is now open for the Society of Interventional Radiology's "Image-guided Interventional Oncology Therapies" Webinar, which will provide the latest updates on percutaneous and transcatheter treatment of liver tumors, kidney tumor ablation and lung tumor ablation.

Correspondence: Dr DJ McConkey, Departments of Urology and Cancer Biology, University of Texas MD Anderson Cancer Center, Box 173, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

Green tea extract has shown promise as cancer prevention agent for oral cancer in patients with a pre-malignant condition known as oral leukoplakia, according to researchers at The University of Texas M. D. Anderson Cancer Center.